$1.35 Million Grant to Better Predict Flu Outbreaks
News Jul 02, 2015
The researchers will look at changes to the flu virus’ envelope – the shell that lets it bind to and infect cells – as the virus adapts to different hosts. By better understanding this, scientists will be better able to determine the risk that a new virus could infect humans and potentially cause a pandemic.
“Previous research has mostly focused on changes in cell attachment and genome replication that are different between avian and human flu viruses, but our working hypothesis is that bird flu is subject to vastly different temperature and environment cycles upon transmission through the fecal-oral route than human flu, which is transmitted through aerosols and lung tissue,” said Tamm, of U.Va.’s Department of Molecular Physiology and Biological Physics. “Our international team of investigators will test the temperature hypothesis of host adaptation by looking at viral envelope remodeling as bird flu strains adapt to human transmission conditions.”
In bird flu’s current form, humans can contract it only through direct contact with birds. In the wake of increasing human infections, however, some scientists fear that a virus could mutate and become transmissible from person to person, possibly resulting in a pandemic akin to the Spanish flu that killed more than 50 million people in the early 20th century.
To better understand how the virus adapts to new hosts, Tamm will bring his expertise in membranes to a team that includes structural biologist Kay Grünewald of the University of Oxford in the United Kingdom; virologist Michael Veit of Freie Universität Berlin in Germany; and biochemist Markus Wenk of the National University of Singapore.
Tamm’s team will receive $450,000 each year for three years. It earned one of only 21 awards made from more than 900 applications. In evaluating Tamm’s grant application, one reviewer commented, “The comprehensive and interdisciplinary approach here … is innovative and highly professional.”
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Malaria Prevention: New Antibody Targets Unique Binding SiteNews
Scientists have discovered a human antibody that, when tested in mice, prevented malaria infection by binding a specific portion of a surface protein found in almost all strains of the malaria parasite worldwide.READ MORE
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018